GB735136A - Improvements in or relating to n-(5-nitro-2-furyl)-alkylidene-3-amino-2-oxazolidones - Google Patents
Improvements in or relating to n-(5-nitro-2-furyl)-alkylidene-3-amino-2-oxazolidonesInfo
- Publication number
- GB735136A GB735136A GB5650/53A GB565053A GB735136A GB 735136 A GB735136 A GB 735136A GB 5650/53 A GB5650/53 A GB 5650/53A GB 565053 A GB565053 A GB 565053A GB 735136 A GB735136 A GB 735136A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxazolidone
- amino
- hydrazino
- nitrofurfurylidene
- nitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- SXINBFXPADXIEY-UHFFFAOYSA-N 5-Nitrofurfural Chemical compound [O-][N+](=O)C1=CC=C(C=O)O1 SXINBFXPADXIEY-UHFFFAOYSA-N 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 239000000047 product Substances 0.000 abstract 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 4
- -1 5-nitrofurfurylidene Chemical group 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 229920002472 Starch Polymers 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 235000019698 starch Nutrition 0.000 abstract 3
- 239000008107 starch Substances 0.000 abstract 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 abstract 2
- UIQGJTTVVCHBCQ-UHFFFAOYSA-N 1-hydrazinylbutan-2-ol Chemical compound CCC(O)CNN UIQGJTTVVCHBCQ-UHFFFAOYSA-N 0.000 abstract 2
- QTKWABVZZUSRPP-UHFFFAOYSA-N 1-hydrazinylhexan-2-ol Chemical compound CCCCC(O)CNN QTKWABVZZUSRPP-UHFFFAOYSA-N 0.000 abstract 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 2
- WDGWKYLQWAUVFT-UHFFFAOYSA-N 2-hydrazinylhexan-1-ol Chemical compound CCCCC(CO)NN WDGWKYLQWAUVFT-UHFFFAOYSA-N 0.000 abstract 2
- ZFOBHMKMJRWBMD-UHFFFAOYSA-N 2-hydrazinylpropan-1-ol Chemical compound OCC(C)NN ZFOBHMKMJRWBMD-UHFFFAOYSA-N 0.000 abstract 2
- KYCJNIUHWNJNCT-UHFFFAOYSA-N 3-Amino-2-oxazolidone Chemical compound NN1CCOC1=O KYCJNIUHWNJNCT-UHFFFAOYSA-N 0.000 abstract 2
- RUPFLBXVOITJRE-UHFFFAOYSA-N 3-hydrazinylbutan-2-ol Chemical compound CC(O)C(C)NN RUPFLBXVOITJRE-UHFFFAOYSA-N 0.000 abstract 2
- ISPQWZWLKSNQCG-UHFFFAOYSA-O [NH3+]C1O[C-]=NC1=O Chemical compound [NH3+]C1O[C-]=NC1=O ISPQWZWLKSNQCG-UHFFFAOYSA-O 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000007795 chemical reaction product Substances 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- TWLDZIZAUAEFBE-UHFFFAOYSA-N n-(ethylamino)hydroxylamine Chemical compound CCNNO TWLDZIZAUAEFBE-UHFFFAOYSA-N 0.000 abstract 2
- DDKNWTWTCVDWQK-UHFFFAOYSA-N 1-bromohexan-2-ol Chemical compound CCCCC(O)CBr DDKNWTWTCVDWQK-UHFFFAOYSA-N 0.000 abstract 1
- YYTSGNJTASLUOY-UHFFFAOYSA-N 1-chloropropan-2-ol Chemical compound CC(O)CCl YYTSGNJTASLUOY-UHFFFAOYSA-N 0.000 abstract 1
- OWXTVVMIMIRMLL-UHFFFAOYSA-N 1-hydrazinylpropan-2-ol Chemical compound CC(O)CNN OWXTVVMIMIRMLL-UHFFFAOYSA-N 0.000 abstract 1
- CWTGJAWJHPAMMZ-UHFFFAOYSA-N 3-nitro-1,3-oxazolidin-2-id-4-one Chemical compound [N+](=O)([O-])N1[CH-]OCC1=O CWTGJAWJHPAMMZ-UHFFFAOYSA-N 0.000 abstract 1
- YAXGBZDYGZBRBQ-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-2-amine Chemical class NC1=NCCO1 YAXGBZDYGZBRBQ-UHFFFAOYSA-N 0.000 abstract 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 abstract 1
- MMWOFVMVTQDQPK-UHFFFAOYSA-N NN1[CH-]OC(C1=O)CCl Chemical compound NN1[CH-]OC(C1=O)CCl MMWOFVMVTQDQPK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- YIUZDGLJEZOSGS-UHFFFAOYSA-N bis(3-methyl-5-nitrofuran-2-yl)methanone Chemical compound CC1=C(OC(=C1)[N+](=O)[O-])C(=O)C=1OC(=CC=1C)[N+](=O)[O-] YIUZDGLJEZOSGS-UHFFFAOYSA-N 0.000 abstract 1
- GKJNMUYGBLNPBP-UHFFFAOYSA-N bis(5-nitrofuran-2-yl)methanone Chemical compound O1C([N+](=O)[O-])=CC=C1C(=O)C1=CC=C([N+]([O-])=O)O1 GKJNMUYGBLNPBP-UHFFFAOYSA-N 0.000 abstract 1
- 239000007859 condensation product Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 abstract 1
- 150000002429 hydrazines Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 239000012280 lithium aluminium hydride Substances 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000006396 nitration reaction Methods 0.000 abstract 1
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 1
- 235000020374 simple syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises compounds of the formula <FORM:0735136/IV (b)/1> where R is hydrogen or alkyl and R1-R4 are hydrogen, alkyl, hydroxyalkyl or haloalkyl (of 1-4 carbon atoms). These are prepared (a) by condensing 5-nitrofurfural or a derivative thereof such as the diacetate (R=H) or a 5-nitrofuryl ketone (R=alkyl) with the appropriate 3-amino-2-oxazolidone; (b) as in (a), using a condensation product of the aminooxazolidone with an aldehyde or ketone which is easily split off, e.g. the N-benzylidene derivative; (c) by ring closure of a compound of the formula <FORM:0735136/IV (b)/2> where X is alkoxy or NH2; (d) from the corresponding 2-imino-oxazolidines by hydrolysis. The amino-oxazolidones used for method (a) are made as in Specification 735,169, and can be prepared in situ. In the examples, (1) the reaction product of b - hydroxyethylhydrazine and diethyl carbonate is condensed with 5-nitrofurfural or its diacetate to give N-(5 - nitrofurfurylidene) - 3 - amino - 2 - oxazolidone; (2) 5-nitrofurfural 2-(b -hydroxyethyl)-semicarbazone is ring-closed with thionyl chloride to N-(5-nitrofurfurylidene)-3-amino-2-imino-oxazolidine hydrochloride and the latter hydrolysed to the 2-oxazolidone; (3) N-(5-nitrofurfurylidene) - N1 - carbethoxy - N1 - (b -hydroxyethyl)-hydrazine is ring-closed with alkali to the product of (1); (4) 3-nitro-2-oxazolidone is electrolytically reduced and the product condensed with 5-nitrofurfural to give the oxazolidone of (1); (5) the following are made by the method of (1): N-(5-nitrofurfurylidene) - 3 - amino - 5 - methyl - 2 - oxazolidone from 1 - hydrazino - 2 - propanol; N - (5-nitrofurfurylidene) - 3 - amino - 4 - methyl - 2-oxazolidone from 2-hydrazino-1-propanol; N-(5 - nitrofurfurylidene) - 3 - amino - 5 - n - butyl-2 - oxazolidone from 1 - hydrazino - 2 - hexanol; N - (5 - nitrofurfurylidene) - 3 - amino - 4 - n-butyl - 2 - oxazolidone from 2 - hydrazino - 1-hexanol; N - (5 - nitrofurfurylidene) - 3 - amino-5 - ethyl - 2 - oxazolidone from 1 - hydrazino-2 - butanol; N - (5 - nitrofurfurylidene) - 3-amino - 5 - methylol - 2 - oxazolidone from the reaction product of 1-chloropropan-2 : 3-diol and hydrazine; N-(5-nitrofurfurylidene)-3-amino - 4 : 5 - dimethyl - 2 - oxazolidone from 3 - hydrazino - 2 - butanol; (6) the last-named product is also obtained from 4 : 4-dimethyl-3-nitro-2-oxazolidone by the method of (4); (7) N - (5 - nitrofurfurylidene) - 3 - amino - 5-chloromethyl-2-oxazolidone is prepared either from 5-nitrofurfural and 3-amino-5-chloromethyl-2-oxazolidone or by treating the corresponding 5-methylol compound with thionyl chloride; (8) methyl 5-nitro-2-furyl ketone is condensed with 3-amino-2-oxazolidone to give N - [a - (5 - nitro - 2 - furyl) - ethylidene] - 3-amino-2-oxazolidone. Hydrazines.-1 - Hydrazino - 2 - propanol and 1 - hydrazino - 2 - hexanol are made by reacting hydrazine hydrate with propylene chlorhydrin and 1-bromo-2-hexanol respectively. Glycerol a -monochlorhydrin may be reacted similarly. 2-Hydrazino-1-propanol and 2-hydrazino-1-hexanol are made by lithium aluminium hydride reduction of ethyl a -hydrazinopropionate and ethyl a -hydrazinocaproate respectively. 1-Hydrazino-2-butanol and 3-hydrazino-2-butanol are prepared from hydrazine hydrate and 1 : 2- or 2 : 3-epoxybutane respectively. N-(5-nitro-furfurylidene)-N1 - carbethoxy - N1 - (b - hydroxyethyl)-hydrazine is made by condensing 5-nitrofurfural with b -hydroxyethylhydrazine and reacting the product with ethyl chloroformate. 4 : 4 - Dimethyl - 3 - nitro - 2 - oxazolidone is prepared by the nitration of 4 : 4-dimethyl-2-oxazolidone.ALSO:Anti-bacterial compositions for oral administration contain as active ingredient a compound of the formula <FORM:0735136/VI/1> where R is hydrogen or alkyl and R1-R4 are hydrogen, alkyl, hydroxyalkyl or haloalkyl (of 1-4 carbon atoms). The compounds can be made up into tablets by granulating with starch paste, drying and adding dry starch, or into lozenges by granulating with sugar syrup and adding powdered sugar, dry starch and a flavouring.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US274066A US2742462A (en) | 1952-02-28 | 1952-02-28 | New n-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidones |
| US565534A US2847416A (en) | 1952-02-28 | 1956-02-15 | Nu-[1-(5-nitro-2-furyl) ethylidene]-3-amino-2-oxazolidone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB735136A true GB735136A (en) | 1955-08-17 |
Family
ID=26956582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5650/53A Expired GB735136A (en) | 1952-02-28 | 1953-02-27 | Improvements in or relating to n-(5-nitro-2-furyl)-alkylidene-3-amino-2-oxazolidones |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US2847416A (en) |
| BE (1) | BE518034A (en) |
| DE (1) | DE1013287B (en) |
| FR (1) | FR1095332A (en) |
| GB (1) | GB735136A (en) |
| NL (2) | NL83304C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1126877B (en) | 1953-08-11 | 1962-04-05 | Norwich Pharma Co | Process for the preparation of 5-nitrofuran derivatives of 3-amino-oxazolidonen- (2) |
| US3004888A (en) * | 1959-01-12 | 1961-10-17 | Pfizer & Co C | Mastitis treatment |
| US3479343A (en) * | 1961-01-09 | 1969-11-18 | Pfizer & Co C | Novel carbazates |
| US3228955A (en) * | 1962-01-18 | 1966-01-11 | Dow Chemical Co | Certain substituted oxazolidinones and pyrrolidinones |
| US4093627A (en) * | 1977-07-01 | 1978-06-06 | Morton-Norwich Products, Inc. | 3-[(4-Chromanylidene)amino]-2-oxazolidinones |
| CN113200974A (en) * | 2021-04-30 | 2021-08-03 | 衢州伟荣药化有限公司 | Pharmaceutical composition, furaltadone hydrochloride and preparation method and application method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2742462A (en) * | 1952-02-28 | 1956-04-17 | Norwich Pharma Co | New n-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidones |
-
1953
- 1953-02-17 NL NL176127A patent/NL83304C/xx active
- 1953-02-27 BE BE518034D patent/BE518034A/xx unknown
- 1953-02-27 GB GB5650/53A patent/GB735136A/en not_active Expired
- 1953-02-27 DE DEE6831A patent/DE1013287B/en active Pending
- 1953-09-14 FR FR1095332D patent/FR1095332A/en not_active Expired
-
1956
- 1956-02-15 US US565534A patent/US2847416A/en not_active Expired - Lifetime
- 1956-02-24 NL NL204866A patent/NL84362C/xx active
Also Published As
| Publication number | Publication date |
|---|---|
| DE1013287B (en) | 1957-08-08 |
| BE518034A (en) | 1955-02-04 |
| NL84362C (en) | 1957-02-15 |
| NL83304C (en) | 1956-11-15 |
| US2847416A (en) | 1958-08-12 |
| FR1095332A (en) | 1955-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0279281B1 (en) | Lipoxygenase inhibiting compounds | |
| JPS63284155A (en) | Lipoxygenase inhibiting compound | |
| US20080306117A1 (en) | Ep4 receptor antagonists | |
| CZ20012112A3 (en) | Phenyl glycine derivative | |
| HU227488B1 (en) | Halogen pyrimidine derivatives, intermediates, preparation and use thereof as fungicides | |
| JPS6312069B2 (en) | ||
| AU4322693A (en) | Fungicidal indole derivatives | |
| US3852338A (en) | N-substituted phenylalanine derivatives | |
| KR920019777A (en) | Substituted 3- (pyridinylamino) -indoles and benzo [b] thiophenes, methods for their preparation and their use as medicaments | |
| RU2196770C2 (en) | Derivatives of isoxazole, pharmaceutical composition based on thereof and method of treatment of autoimmune and inflammatory diseases | |
| US4085221A (en) | Ethanolamine derivatives | |
| US7507754B2 (en) | EP4 receptor antagonists | |
| GB1113618A (en) | 3-hydroxyisoazole derivatives | |
| KR930703279A (en) | Lipoxygenase-inhibiting hydroxamic acid and N-hydroxyurea derivatives | |
| GB1085106A (en) | Process for the preparation of substituted oxazolidones | |
| WO2003099812A1 (en) | Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine | |
| NO176478C (en) | Analogous Process for the Preparation of Therapeutically Active Hydantoin Derivatives, and Intermediates for Use in the Process | |
| CA1182824A (en) | P-oxooxazolidinylbenzene sulfonamides as antibacterial agents | |
| US2847416A (en) | Nu-[1-(5-nitro-2-furyl) ethylidene]-3-amino-2-oxazolidone | |
| US6909005B1 (en) | One post synthesis of 2-oxazolidinone derivatives | |
| US4554282A (en) | Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method | |
| GB843602A (en) | Improvements in or relating to the manufacture of nitrofuran derivatives | |
| US2918466A (en) | Antimicrobial chemical compounds derived from alkoxyphenyl glycidic acid | |
| LU81832A1 (en) | NOVEL ACYL-1H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR PREPARATION PROCESS | |
| GB741228A (en) | Improvements in or relating to triazole compounds |